Show simple item record

dc.contributor.authorBlanc, F-X
dc.contributor.authorSok, T
dc.contributor.authorLaureillard, D
dc.contributor.authorBorand, L
dc.contributor.authorRekacewicz, C
dc.contributor.authorNerrienet, E
dc.contributor.authorMadec, Y
dc.contributor.authorMarcy, O
dc.contributor.authorChan, S
dc.contributor.authorPrak, N
dc.contributor.authorKim, C
dc.contributor.authorLak, K K
dc.contributor.authorHak, C
dc.contributor.authorDim, B
dc.contributor.authorSin, C I
dc.contributor.authorSun, S
dc.contributor.authorGuillard, B
dc.contributor.authorSar, B
dc.contributor.authorVong, S
dc.contributor.authorFernandez, M
dc.contributor.authorFox, L
dc.contributor.authorDelfraissy, J-F
dc.contributor.authorGoldfeld, A E
dc.date.accessioned2012-04-24T14:01:36Z
dc.date.available2012-04-24T14:01:36Z
dc.date.issued2011-10-20
dc.identifier.citationEarlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. 2011, 365 (16):1471-81 N. Engl. J. Med.en_GB
dc.identifier.issn1533-4406
dc.identifier.pmid22010913
dc.identifier.doi10.1056/NEJMoa1013911
dc.identifier.urihttp://hdl.handle.net/10144/220294
dc.description.abstractTuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.
dc.language.isoenen
dc.rightsArchived with thanks to The New England Journal of Medicine's open access policy.en_GB
dc.subject.meshAIDS-Related Opportunistic Infectionsen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-Retroviral Agentsen_GB
dc.subject.meshAntitubercular Agentsen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshDrug Administration Scheduleen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshFollow-Up Studiesen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshKaplan-Meier Estimateen_GB
dc.subject.meshMaleen_GB
dc.subject.meshTuberculosisen_GB
dc.subject.meshViral Loaden_GB
dc.titleEarlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.en
dc.contributor.departmentPneumology Unit, Internal Medicine Department, Bicêtre Hospital, Assistance Publique–Hôpitaux de Paris, Le Kremlin-Bicêtre, France. xavier.blanc@bct.aphp.fren_GB
dc.identifier.journalNew England Journal of Medicineen_GB
refterms.dateFOA2019-03-04T09:42:27Z
html.description.abstractTuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.


Files in this item

Thumbnail
Name:
NEJM Camelia.pdf
Size:
662.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record